| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 2.42e-06 | 103 | 42 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | interleukin-23 binding | 4.32e-06 | 2 | 42 | 2 | GO:0042019 | |
| GeneOntologyMolecularFunction | interleukin-23 receptor activity | 4.32e-06 | 2 | 42 | 2 | GO:0042020 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.25e-05 | 144 | 42 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | interleukin-12 receptor binding | 4.30e-05 | 5 | 42 | 2 | GO:0005143 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.50e-05 | 188 | 42 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | lysozyme activity | 2.35e-04 | 11 | 42 | 2 | GO:0003796 | |
| GeneOntologyMolecularFunction | cytokine binding | 3.26e-04 | 157 | 42 | 4 | GO:0019955 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 3.32e-04 | 13 | 42 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | peptidoglycan muralytic activity | 4.46e-04 | 15 | 42 | 2 | GO:0061783 | |
| GeneOntologyMolecularFunction | hexosaminidase activity | 5.76e-04 | 17 | 42 | 2 | GO:0015929 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 8.01e-04 | 20 | 42 | 2 | GO:0004675 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.36e-03 | 26 | 42 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 1.36e-03 | 26 | 42 | 2 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 1.36e-03 | 26 | 42 | 2 | GO:0019707 | |
| GeneOntologyMolecularFunction | Notch binding | 1.47e-03 | 27 | 42 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 1.81e-03 | 30 | 42 | 2 | GO:0016417 | |
| GeneOntologyMolecularFunction | palmitoyltransferase activity | 2.75e-03 | 37 | 42 | 2 | GO:0016409 | |
| GeneOntologyBiologicalProcess | interleukin-23-mediated signaling pathway | 2.54e-05 | 4 | 43 | 2 | GO:0038155 | |
| GeneOntologyCellularComponent | interleukin-23 receptor complex | 2.47e-05 | 4 | 43 | 2 | GO:0072536 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 9.45e-05 | 530 | 43 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | microfibril | 3.18e-04 | 13 | 43 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.50e-04 | 656 | 43 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.56e-04 | 658 | 43 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | cell surface | 1.71e-03 | 1111 | 43 | 8 | GO:0009986 | |
| Domain | LYZL1/LYZL2 | 4.94e-06 | 2 | 42 | 2 | IPR030057 | |
| Domain | Jagged/Serrate | 4.94e-06 | 2 | 42 | 2 | IPR026219 | |
| Domain | VWC_out | 9.99e-06 | 19 | 42 | 3 | SM00215 | |
| Domain | Growth_fac_rcpt_ | 2.53e-05 | 156 | 42 | 5 | IPR009030 | |
| Domain | DSL | 2.95e-05 | 4 | 42 | 2 | PF01414 | |
| Domain | DSL | 2.95e-05 | 4 | 42 | 2 | SM00051 | |
| Domain | EGF_CA | 4.10e-05 | 86 | 42 | 4 | PF07645 | |
| Domain | DSL | 4.92e-05 | 5 | 42 | 2 | IPR001774 | |
| Domain | DSL | 4.92e-05 | 5 | 42 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 4.92e-05 | 5 | 42 | 2 | IPR011651 | |
| Domain | MNNL | 4.92e-05 | 5 | 42 | 2 | PF07657 | |
| Domain | EGF_Ca-bd_CS | 6.58e-05 | 97 | 42 | 4 | IPR018097 | |
| Domain | EGF_CA | 7.12e-05 | 99 | 42 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.41e-05 | 100 | 42 | 4 | PS00010 | |
| Domain | VWC | 8.44e-05 | 38 | 42 | 3 | SM00214 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.29e-05 | 106 | 42 | 4 | IPR000152 | |
| Domain | TB | 1.03e-04 | 7 | 42 | 2 | PF00683 | |
| Domain | Glyco_hydro_22_lys | 1.03e-04 | 7 | 42 | 2 | IPR000974 | |
| Domain | Glyco_hydro_22_CS | 1.03e-04 | 7 | 42 | 2 | IPR019799 | |
| Domain | VWF_dom | 1.14e-04 | 42 | 42 | 3 | IPR001007 | |
| Domain | LACTALBUMIN_LYSOZYME_2 | 1.37e-04 | 8 | 42 | 2 | PS51348 | |
| Domain | Lys | 1.37e-04 | 8 | 42 | 2 | PF00062 | |
| Domain | - | 1.37e-04 | 8 | 42 | 2 | 3.90.290.10 | |
| Domain | LACTALBUMIN_LYSOZYME_1 | 1.37e-04 | 8 | 42 | 2 | PS00128 | |
| Domain | LYZ1 | 1.37e-04 | 8 | 42 | 2 | SM00263 | |
| Domain | Glyco_hydro_22 | 1.37e-04 | 8 | 42 | 2 | IPR001916 | |
| Domain | EGF_CA | 1.60e-04 | 122 | 42 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.70e-04 | 124 | 42 | 4 | IPR001881 | |
| Domain | TB | 1.76e-04 | 9 | 42 | 2 | PS51364 | |
| Domain | TB_dom | 1.76e-04 | 9 | 42 | 2 | IPR017878 | |
| Domain | Lysozyme-like_dom | 2.20e-04 | 10 | 42 | 2 | IPR023346 | |
| Domain | EGF_1 | 2.57e-04 | 255 | 42 | 5 | PS00022 | |
| Domain | EGF-like_CS | 2.86e-04 | 261 | 42 | 5 | IPR013032 | |
| Domain | zf-DHHC | 1.21e-03 | 23 | 42 | 2 | PF01529 | |
| Domain | DHHC | 1.43e-03 | 25 | 42 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 1.43e-03 | 25 | 42 | 2 | IPR001594 | |
| Domain | hEGF | 1.80e-03 | 28 | 42 | 2 | PF12661 | |
| Domain | EGF_3 | 1.88e-03 | 235 | 42 | 4 | PS50026 | |
| Domain | EGF | 1.88e-03 | 235 | 42 | 4 | SM00181 | |
| Domain | ARF | 1.93e-03 | 29 | 42 | 2 | PS51417 | |
| Domain | Small_GTPase_ARF | 1.93e-03 | 29 | 42 | 2 | IPR024156 | |
| Domain | Arf | 2.20e-03 | 31 | 42 | 2 | PF00025 | |
| Domain | EGF-like_dom | 2.32e-03 | 249 | 42 | 4 | IPR000742 | |
| Domain | Small_GTPase_ARF/SAR | 2.49e-03 | 33 | 42 | 2 | IPR006689 | |
| Domain | EGF | 2.84e-03 | 126 | 42 | 3 | PF00008 | |
| Domain | EGF_2 | 2.90e-03 | 265 | 42 | 4 | PS01186 | |
| Domain | VWFC_1 | 2.96e-03 | 36 | 42 | 2 | PS01208 | |
| Domain | VWFC_2 | 3.30e-03 | 38 | 42 | 2 | PS50184 | |
| Domain | fn3 | 5.74e-03 | 162 | 42 | 3 | PF00041 | |
| Domain | Glycoside_hydrolase_SF | 6.33e-03 | 53 | 42 | 2 | IPR017853 | |
| Domain | EGF_extracell | 8.05e-03 | 60 | 42 | 2 | IPR013111 | |
| Domain | EGF_2 | 8.05e-03 | 60 | 42 | 2 | PF07974 | |
| Domain | FN3 | 8.27e-03 | 185 | 42 | 3 | SM00060 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 1.04e-04 | 7 | 32 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.39e-04 | 8 | 32 | 2 | M47850 | |
| Pathway | REACTOME_INTERLEUKIN_23_SIGNALING | 1.39e-04 | 8 | 32 | 2 | MM15619 | |
| Pathway | REACTOME_INTERLEUKIN_23_SIGNALING | 1.78e-04 | 9 | 32 | 2 | M27896 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.78e-04 | 9 | 32 | 2 | M47866 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY | 2.22e-04 | 10 | 32 | 2 | M47907 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 3.83e-04 | 13 | 32 | 2 | M47423 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 5.15e-04 | 15 | 32 | 2 | M12101 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 5.15e-04 | 15 | 32 | 2 | M1262 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 5.15e-04 | 15 | 32 | 2 | MM14959 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 5.15e-04 | 15 | 32 | 2 | M27202 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 5.15e-04 | 15 | 32 | 2 | MM14965 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 5.15e-04 | 15 | 32 | 2 | MM14961 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.30e-04 | 300 | 32 | 5 | M610 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 5.87e-04 | 16 | 32 | 2 | M47424 | |
| Pathway | REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING | 5.87e-04 | 16 | 32 | 2 | MM15127 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 6.65e-04 | 17 | 32 | 2 | M39389 | |
| Pathway | REACTOME_ATTACHMENT_AND_ENTRY | 8.33e-04 | 19 | 32 | 2 | M41729 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 8.33e-04 | 19 | 32 | 2 | MM15594 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 1.12e-03 | 22 | 32 | 2 | M39480 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.12e-03 | 22 | 32 | 2 | M27210 | |
| Pathway | WP_BLOOD_CLOTTING_CASCADE | 1.23e-03 | 23 | 32 | 2 | MM15936 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.45e-03 | 25 | 32 | 2 | M27879 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.69e-03 | 27 | 32 | 2 | M39545 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 1.69e-03 | 27 | 32 | 2 | M760 | |
| Pathway | REACTOME_INTEGRIN_SIGNALING | 1.82e-03 | 28 | 32 | 2 | MM14958 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 2.23e-03 | 31 | 32 | 2 | M592 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.37e-03 | 32 | 32 | 2 | MM14854 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 2.52e-03 | 33 | 32 | 2 | M604 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.63e-03 | 258 | 32 | 4 | MM14572 | |
| Pathway | REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS | 3.16e-03 | 37 | 32 | 2 | M45028 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.16e-03 | 37 | 32 | 2 | M27134 | |
| Pathway | PID_IL23_PATHWAY | 3.16e-03 | 37 | 32 | 2 | M196 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.33e-03 | 38 | 32 | 2 | MM15456 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.33e-03 | 38 | 32 | 2 | MM14874 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 3.51e-03 | 39 | 32 | 2 | MM15272 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.51e-03 | 39 | 32 | 2 | M10735 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.51e-03 | 39 | 32 | 2 | MM14604 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.51e-03 | 39 | 32 | 2 | MM14601 | |
| Pathway | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | 3.51e-03 | 39 | 32 | 2 | M2844 | |
| Pathway | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | 3.51e-03 | 39 | 32 | 2 | MM14559 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 3.69e-03 | 40 | 32 | 2 | M27557 | |
| Pathway | WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING | 4.25e-03 | 43 | 32 | 2 | M45516 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.45e-03 | 44 | 32 | 2 | M26969 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 4.45e-03 | 44 | 32 | 2 | M875 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 4.65e-03 | 45 | 32 | 2 | M27623 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 4.65e-03 | 45 | 32 | 2 | M39571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 4.65e-03 | 45 | 32 | 2 | M47408 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 4.85e-03 | 46 | 32 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 5.06e-03 | 47 | 32 | 2 | M7946 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 5.06e-03 | 47 | 32 | 2 | M646 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.49e-03 | 49 | 32 | 2 | M618 | |
| Pubmed | 3.58e-07 | 118 | 43 | 5 | 21078624 | ||
| Pubmed | 1.30e-06 | 153 | 43 | 5 | 25037231 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 29287995 | ||
| Pubmed | NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. | 1.49e-06 | 2 | 43 | 2 | 24708907 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 38750026 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 23662788 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 28111308 | ||
| Pubmed | Distinctive expression of interleukin-23 receptor subunits on human Th17 and γδ T cells. | 1.49e-06 | 2 | 43 | 2 | 27645493 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 11549580 | ||
| Pubmed | Notch signaling drives multiple myeloma induced osteoclastogenesis. | 4.48e-06 | 3 | 43 | 2 | 25257302 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 23673666 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 24191040 | ||
| Pubmed | Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. | 4.48e-06 | 3 | 43 | 2 | 9351824 | |
| Pubmed | Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. | 4.48e-06 | 3 | 43 | 2 | 9716576 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 24907271 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 23530123 | ||
| Pubmed | Expression of Notch ligands, Jagged1, 2 and Delta1 in antigen presenting cells in mice. | 4.48e-06 | 3 | 43 | 2 | 11841846 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 12429738 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 15114670 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 10837254 | ||
| Pubmed | Notch ligands transduce different magnitudes of signaling critical for determination of T-cell fate. | 8.94e-06 | 4 | 43 | 2 | 20602435 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 15611103 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 9315665 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 20819128 | ||
| Pubmed | Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. | 8.94e-06 | 4 | 43 | 2 | 12421946 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 37966490 | ||
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 8.94e-06 | 4 | 43 | 2 | 20040020 | |
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 8.94e-06 | 4 | 43 | 2 | 11104663 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 9858728 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 25371211 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 16157329 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 24398584 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 19897194 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 30244870 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 1.49e-05 | 5 | 43 | 2 | 11006133 | |
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 1.49e-05 | 5 | 43 | 2 | 15064243 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 21602525 | ||
| Pubmed | Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. | 1.49e-05 | 5 | 43 | 2 | 11891199 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 15788413 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 24586521 | ||
| Pubmed | Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo. | 1.49e-05 | 5 | 43 | 2 | 16824188 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 12175503 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 19349279 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 10958687 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 26987707 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 8635876 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 16688182 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 17236132 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 29563520 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.38e-05 | 135 | 43 | 4 | 28675934 | |
| Pubmed | 2.99e-05 | 143 | 43 | 4 | 20424473 | ||
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 10383933 | ||
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 10079256 | ||
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 19998449 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 3.12e-05 | 7 | 43 | 2 | 12846471 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 10930463 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 3.12e-05 | 7 | 43 | 2 | 9384381 | |
| Pubmed | Evidence for a Notch1-mediated transition during olfactory ensheathing cell development. | 3.12e-05 | 7 | 43 | 2 | 27271278 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 12023369 | ||
| Pubmed | 3.24e-05 | 146 | 43 | 4 | 27068509 | ||
| Pubmed | DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. | 4.16e-05 | 8 | 43 | 2 | 17626181 | |
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 4.16e-05 | 8 | 43 | 2 | 22652674 | |
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 18245384 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 27339457 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 9858718 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 11044610 | ||
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 11118901 | ||
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 16245338 | ||
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 12122015 | ||
| Pubmed | Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. | 5.35e-05 | 9 | 43 | 2 | 11944948 | |
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 11114383 | ||
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 5.35e-05 | 9 | 43 | 2 | 10837027 | |
| Pubmed | 5.47e-05 | 167 | 43 | 4 | 22159717 | ||
| Pubmed | 6.56e-05 | 175 | 43 | 4 | 28071719 | ||
| Pubmed | Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress. | 6.68e-05 | 10 | 43 | 2 | 26542370 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 6.68e-05 | 10 | 43 | 2 | 23665443 | |
| Pubmed | 6.68e-05 | 10 | 43 | 2 | 12082590 | ||
| Pubmed | IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12. | 6.68e-05 | 10 | 43 | 2 | 19088061 | |
| Pubmed | Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction. | 6.68e-05 | 10 | 43 | 2 | 20036902 | |
| Pubmed | Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. | 8.15e-05 | 11 | 43 | 2 | 15875024 | |
| Pubmed | Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. | 8.15e-05 | 11 | 43 | 2 | 16482511 | |
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 10878608 | ||
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 12866128 | ||
| Pubmed | Genome-wide association study of age at menarche in African-American women. | 9.78e-05 | 12 | 43 | 2 | 23599027 | |
| Pubmed | Dll3 is expressed in developing hair cells in the mammalian cochlea. | 9.78e-05 | 12 | 43 | 2 | 17823936 | |
| Pubmed | p53 Activity Dominates That of p73 upon Mdm4 Loss in Development and Tumorigenesis. | 9.78e-05 | 12 | 43 | 2 | 26527653 | |
| Pubmed | 9.78e-05 | 12 | 43 | 2 | 15465494 | ||
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 18848323 | ||
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 1.15e-04 | 13 | 43 | 2 | 31202705 | |
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 11171333 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.15e-04 | 13 | 43 | 2 | 11578869 | |
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 11934853 | ||
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 1.15e-04 | 13 | 43 | 2 | 20558824 | |
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 34838591 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 18528438 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 16581250 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 28192800 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 16005629 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 14757642 | ||
| Pubmed | Notch1 is required for neuronal and glial differentiation in the cerebellum. | 1.35e-04 | 14 | 43 | 2 | 11807030 | |
| Interaction | MFAP5 interactions | 8.39e-08 | 52 | 43 | 5 | int:MFAP5 | |
| Interaction | CACNA1A interactions | 6.24e-06 | 123 | 43 | 5 | int:CACNA1A | |
| Interaction | NTN5 interactions | 1.77e-05 | 24 | 43 | 3 | int:NTN5 | |
| Interaction | ATXN7 interactions | 8.49e-05 | 109 | 43 | 4 | int:ATXN7 | |
| Interaction | JAG2 interactions | 8.80e-05 | 110 | 43 | 4 | int:JAG2 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.59e-05 | 4 | 30 | 2 | 628 | |
| GeneFamily | Lysozymes, c-type | 9.51e-05 | 9 | 30 | 2 | 1174 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 7.18e-04 | 24 | 30 | 2 | 76 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.20e-03 | 31 | 30 | 2 | 357 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.84e-07 | 191 | 42 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.79e-07 | 196 | 42 | 6 | M3008 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 1.11e-06 | 115 | 42 | 5 | M45752 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 3.23e-06 | 780 | 42 | 9 | M2324 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 4.17e-06 | 805 | 42 | 9 | MM1067 | |
| Coexpression | NABA_CORE_MATRISOME | 4.34e-06 | 270 | 42 | 6 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 4.83e-06 | 275 | 42 | 6 | M5884 | |
| Coexpression | SANA_TNF_SIGNALING_DN | 1.05e-05 | 85 | 42 | 4 | M19467 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR | 3.23e-05 | 113 | 42 | 4 | M39153 | |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 1.17e-04 | 59 | 42 | 3 | M10156 | |
| Coexpression | ROZANOV_MMP14_CORRELATED | 1.37e-04 | 11 | 42 | 2 | M2987 | |
| Coexpression | SASAKI_TARGETS_OF_TP73_AND_TP63 | 1.64e-04 | 12 | 42 | 2 | M17374 | |
| Coexpression | ESC_J1_UP_LATE.V1_UP | 2.23e-04 | 186 | 42 | 4 | M2768 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 2.25e-04 | 14 | 42 | 2 | M48002 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS | 2.32e-04 | 188 | 42 | 4 | M40287 | |
| Coexpression | GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP | 2.82e-04 | 198 | 42 | 4 | M7875 | |
| Coexpression | GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN | 2.88e-04 | 199 | 42 | 4 | M9398 | |
| Coexpression | GSE17721_LPS_VS_CPG_2H_BMDC_DN | 2.93e-04 | 200 | 42 | 4 | M3991 | |
| Coexpression | GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP | 2.93e-04 | 200 | 42 | 4 | M6965 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.97e-04 | 16 | 42 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.97e-04 | 16 | 42 | 2 | MM1296 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL | 3.58e-04 | 384 | 42 | 5 | M45735 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | 3.78e-04 | 604 | 42 | 6 | M45760 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 8.69e-10 | 200 | 43 | 7 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.69e-10 | 200 | 43 | 7 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 8.69e-10 | 200 | 43 | 7 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.69e-10 | 200 | 43 | 7 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-08 | 178 | 43 | 6 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-08 | 178 | 43 | 6 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-08 | 186 | 43 | 6 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-08 | 190 | 43 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-08 | 198 | 43 | 6 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.80e-08 | 200 | 43 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.81e-07 | 154 | 43 | 5 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-07 | 169 | 43 | 5 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-07 | 169 | 43 | 5 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.38e-07 | 176 | 43 | 5 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.38e-07 | 176 | 43 | 5 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.38e-07 | 176 | 43 | 5 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-07 | 177 | 43 | 5 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-07 | 182 | 43 | 5 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 9.19e-07 | 184 | 43 | 5 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.44e-07 | 185 | 43 | 5 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.70e-07 | 186 | 43 | 5 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.02e-06 | 188 | 43 | 5 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-06 | 189 | 43 | 5 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-06 | 189 | 43 | 5 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 190 | 43 | 5 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-06 | 191 | 43 | 5 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-06 | 191 | 43 | 5 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-06 | 191 | 43 | 5 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-06 | 192 | 43 | 5 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-06 | 192 | 43 | 5 | 389d5e6d0689371bfe1d0b06e92e0e6e5573567b | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 1.16e-06 | 193 | 43 | 5 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | IPF-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 1.16e-06 | 193 | 43 | 5 | 70a9aadda83a97e06e9bc2d1327ce60dd3c58767 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 193 | 43 | 5 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-06 | 193 | 43 | 5 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-06 | 196 | 43 | 5 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-06 | 197 | 43 | 5 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.29e-06 | 197 | 43 | 5 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-06 | 198 | 43 | 5 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-06 | 199 | 43 | 5 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 199 | 43 | 5 | a3ec743b978ba8fdf1677b4971b5731f50ddd30f | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-06 | 199 | 43 | 5 | 9b02acae6325b0ac9642438a4431285ff396e5fe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-06 | 200 | 43 | 5 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-06 | 116 | 43 | 4 | a07f16917c66ce25f23ebef350d693cc4c324075 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-05 | 157 | 43 | 4 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-05 | 157 | 43 | 4 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.75e-05 | 161 | 43 | 4 | f4f5d6eaa32169de699c8ff8e8ae35179c8e25c0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 161 | 43 | 4 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.88e-05 | 164 | 43 | 4 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-05 | 165 | 43 | 4 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 165 | 43 | 4 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | Control-Lymphocyte-T_NK-MAIT|Control / Disease, Lineage and Cell Type | 2.11e-05 | 169 | 43 | 4 | 8c2aac193a9c500f01a99a2ee530839c851b6222 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 169 | 43 | 4 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 169 | 43 | 4 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 170 | 43 | 4 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 170 | 43 | 4 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-05 | 170 | 43 | 4 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 170 | 43 | 4 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-05 | 172 | 43 | 4 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.32e-05 | 173 | 43 | 4 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.32e-05 | 173 | 43 | 4 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-05 | 174 | 43 | 4 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.37e-05 | 174 | 43 | 4 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-05 | 175 | 43 | 4 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-05 | 175 | 43 | 4 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.48e-05 | 176 | 43 | 4 | 10c1f31c27e54b70f58f0b0086ac74dee2ce4197 | |
| ToppCell | Entopeduncular-Endothelial-MURAL|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.48e-05 | 176 | 43 | 4 | b8e52bec78876562a25f0b0de502aa9372b28bd2 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-05 | 176 | 43 | 4 | 27e6b3ae41068d6cfdda3d46da7df2a27567140e | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-05 | 176 | 43 | 4 | d6a5470af9592f34a741265f2ea9651c05c3add3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.53e-05 | 177 | 43 | 4 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 178 | 43 | 4 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 178 | 43 | 4 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 178 | 43 | 4 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 179 | 43 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 180 | 43 | 4 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 181 | 43 | 4 | 429df38438d5a7ff490c9ede34b69e2970c7ded2 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 181 | 43 | 4 | 395cf5aa2d89b05328ab516b8c89401020b6d830 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-05 | 181 | 43 | 4 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 181 | 43 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-05 | 182 | 43 | 4 | 3cbeaf7904a76c32137a00abb20e302d3d3c8bb8 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-05 | 182 | 43 | 4 | 0639011cdd1c437ea8b7230896a4e6e5d7244ac2 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.83e-05 | 182 | 43 | 4 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-05 | 182 | 43 | 4 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.83e-05 | 182 | 43 | 4 | da61e7cb2537c567968d8bd8baf537ecdff0ab18 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 182 | 43 | 4 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | Cerebellum-Endothelial-MURAL|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.83e-05 | 182 | 43 | 4 | b2f03f61aebb5920595fed8b9d6799a09353419b | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-05 | 183 | 43 | 4 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-05 | 183 | 43 | 4 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-05 | 183 | 43 | 4 | 06ac66726ec53db810ebb90ec69cfdb903da53f6 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-05 | 183 | 43 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-05 | 183 | 43 | 4 | fc9a7ba148c22d0c8a46f6bc56c772929ac496f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 184 | 43 | 4 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 2.95e-05 | 184 | 43 | 4 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-05 | 184 | 43 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 184 | 43 | 4 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-05 | 185 | 43 | 4 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 185 | 43 | 4 | eeb6f55a6f79adf80247baa2c4b0df44553557ad | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 185 | 43 | 4 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 185 | 43 | 4 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 185 | 43 | 4 | f262b441ea3fe7f69dff33d5f171000371f3a3e5 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-05 | 185 | 43 | 4 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| Drug | AC1L9R2Z | 1.41e-05 | 168 | 42 | 5 | CID000453624 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA | 2.81e-05 | 194 | 42 | 5 | 1020_UP | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 3.02e-05 | 197 | 42 | 5 | 7533_UP | |
| Drug | 1,6-anhydromuramic acid | 3.31e-05 | 5 | 42 | 2 | CID005492540 | |
| Drug | GeH4 | 3.36e-05 | 34 | 42 | 3 | CID000023984 | |
| Drug | muramate | 3.67e-05 | 35 | 42 | 3 | CID000433580 | |
| Drug | AC1L1D9C | 4.09e-05 | 349 | 42 | 6 | CID000002250 | |
| Drug | rhamnose | 4.57e-05 | 356 | 42 | 6 | CID000000840 | |
| Drug | muramic lactam | 4.96e-05 | 6 | 42 | 2 | CID000161874 | |
| Drug | C-MBT | 4.96e-05 | 6 | 42 | 2 | CID002723842 | |
| Drug | 5-mercaptouridine monophosphate | 4.96e-05 | 6 | 42 | 2 | CID003081517 | |
| Disease | Glioblastoma | 1.97e-04 | 79 | 42 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 2.36e-04 | 84 | 42 | 3 | C0334588 | |
| Disease | RS-10-hydroxywarfarin measurement | 3.71e-04 | 98 | 42 | 3 | EFO_0803330 | |
| Disease | Glioblastoma Multiforme | 5.34e-04 | 111 | 42 | 3 | C1621958 | |
| Disease | Carcinoma, Pancreatic Ductal | 5.35e-04 | 24 | 42 | 2 | C0887833 | |
| Disease | pulmonary hypertension (is_implicated_in) | 8.39e-04 | 30 | 42 | 2 | DOID:6432 (is_implicated_in) | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 8.39e-04 | 30 | 42 | 2 | EFO_0004629, HP_0002140 | |
| Disease | response to allopurinol, uric acid measurement | 9.55e-04 | 32 | 42 | 2 | EFO_0004761, EFO_0006337 | |
| Disease | Behcet's disease (is_implicated_in) | 1.21e-03 | 36 | 42 | 2 | DOID:13241 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CMGPIWSSYYGNCRS | 86 | Q0P5N6 | |
| DWRGAICSGCYAQMY | 991 | Q8WUJ3 | |
| GFSLGNWICMAYYES | 41 | Q6UWQ5 | |
| GFSLGNWICMAYYES | 41 | Q7Z4W2 | |
| CMAVVYDRVWCGYKN | 1051 | Q9UPT6 | |
| CGFFGDAEYEMCVRW | 1511 | Q2M2H8 | |
| DCGRMLTRMWYCSYC | 251 | P51654 | |
| YTCDQYGNKACMDGW | 221 | Q9Y219 | |
| YRVYCDMNTENGGWT | 266 | P02675 | |
| LPYGRSYWMCCRRAD | 556 | Q6PJ61 | |
| TYTECCCLYGEAWGM | 1546 | Q14766 | |
| YEEGCQSLMEYAWGR | 61 | Q96FX8 | |
| DWGYPYNMMVTRRCC | 226 | P31512 | |
| CMVYQYGNFSWDLAG | 621 | P08473 | |
| LWMGIGSACNYYNRV | 66 | P11511 | |
| WYELRMRACNSAGCG | 1546 | Q8TD84 | |
| AYCMGRMNSDCWYLY | 146 | P17707 | |
| YEYSGNMTCTWNAGK | 136 | Q5VWK5 | |
| WSRESGAMGQEKCYY | 401 | P42701 | |
| TYTECCCLYGEAWGM | 1371 | Q8N2S1 | |
| CGGFSQMYACVCDWL | 156 | Q5VZK9 | |
| QMYACVCDWLGFSYR | 161 | Q5VZK9 | |
| DCCVSYGGMWYLKGT | 691 | Q9NVU0 | |
| YLMGCNYFWMLCEGI | 221 | Q16602 | |
| SYGGCMAQLYFLTWA | 111 | Q8NGR1 | |
| IASYYCDCLPGWMGQ | 431 | P78504 | |
| YCASCICYMLNNWSG | 176 | P53609 | |
| YCMWRGYEYCRLDGQ | 521 | P28370 | |
| CDRCMVGYWGFGDYG | 431 | Q9HB63 | |
| EMCYWGSKYCADQQP | 216 | A6NDU8 | |
| CYNWYGDGRIMIGFS | 236 | Q8NEZ3 | |
| CCGGISYKDWSQNMY | 156 | Q86UF1 | |
| WNENYGRAACRDMGY | 176 | O15393 | |
| YARTCAQEGMVLYGW | 271 | P04275 | |
| WMQYLREGYTVCVDC | 191 | Q8IVN8 | |
| CCCLSYFYMVSAWGG | 251 | Q8TCJ2 | |
| CYCYCGGPGEWYLRM | 196 | Q5T6S3 | |
| FMTLGCVYCSYGSWD | 206 | Q969W1 | |
| FMICWMIYGCISYWG | 491 | Q8IUH5 | |
| DFGERWGNYCKMCSY | 506 | O95789 | |
| SPYYCGTCGRWFRAM | 571 | Q8TF50 | |
| WYIQGCDARSGMGLY | 541 | P36406 | |
| TYWATDCGNYAGALM | 1411 | Q8IZF0 | |
| GWRDMGYTYLNIDDC | 66 | P17050 |